CA2547775C - In ovo vaccination of campylobacter in avian species - Google Patents

In ovo vaccination of campylobacter in avian species Download PDF

Info

Publication number
CA2547775C
CA2547775C CA2547775A CA2547775A CA2547775C CA 2547775 C CA2547775 C CA 2547775C CA 2547775 A CA2547775 A CA 2547775A CA 2547775 A CA2547775 A CA 2547775A CA 2547775 C CA2547775 C CA 2547775C
Authority
CA
Canada
Prior art keywords
live cells
campylobacter
jejuni
ovo
bird
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2547775A
Other languages
English (en)
French (fr)
Other versions
CA2547775A1 (en
Inventor
Tonia Sue Agin
Everett Lee Rosey
Frederick Henry Weber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zoetis Services LLC
Original Assignee
Pfizer Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc filed Critical Pfizer Products Inc
Publication of CA2547775A1 publication Critical patent/CA2547775A1/en
Application granted granted Critical
Publication of CA2547775C publication Critical patent/CA2547775C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA2547775A 2003-12-03 2004-11-22 In ovo vaccination of campylobacter in avian species Expired - Fee Related CA2547775C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US52668103P 2003-12-03 2003-12-03
US60/526,681 2003-12-03
PCT/IB2004/003806 WO2005053737A1 (en) 2003-12-03 2004-11-22 In ovo vaccination of campylobacter in avian species

Publications (2)

Publication Number Publication Date
CA2547775A1 CA2547775A1 (en) 2005-06-16
CA2547775C true CA2547775C (en) 2012-01-03

Family

ID=34652463

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2547775A Expired - Fee Related CA2547775C (en) 2003-12-03 2004-11-22 In ovo vaccination of campylobacter in avian species

Country Status (7)

Country Link
US (2) US8092808B2 (enExample)
EP (1) EP1691831B1 (enExample)
JP (1) JP4602347B2 (enExample)
AU (1) AU2004294810C1 (enExample)
CA (1) CA2547775C (enExample)
ES (1) ES2422885T3 (enExample)
WO (1) WO2005053737A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2561673C2 (ru) 2006-03-30 2015-08-27 Эмбрекс, Инк. Способы и композиции для вакцинации домашней птицы
TWI423814B (zh) * 2006-09-01 2014-01-21 Genticel 用於引發特異性細胞毒性ｔ淋巴細胞（ｃｔｌ）反應之組成物，包含一淋巴去除性化合物以及一含有抗原序列且以專業化抗原呈現細胞為標靶之分子
WO2009012589A1 (en) * 2007-07-23 2009-01-29 University Of Saskatchewan Vaccines and methods for treatment or prevention of gram negative bacterial infection in a vertebrate subject
US10829524B2 (en) * 2014-05-09 2020-11-10 Universiteit Utrecht Holding B.V. CATH2 derivatives
US12194157B2 (en) 2020-04-09 2025-01-14 Finncure Oy Carrier for targeted delivery to a host
AU2021252164A1 (en) 2020-04-09 2022-12-15 Finncure Oy Mimetic nanoparticles for preventing the spreading and lowering the infection rate of novel coronaviruses

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4040388A (en) 1976-02-27 1977-08-09 Agrimatic Corporation Method and apparatus for automatic egg injection
US4593646A (en) 1982-06-01 1986-06-10 Agrimatic Corporation Egg injection method and apparatus
US4469047A (en) 1983-10-25 1984-09-04 Miller Gary E Apparatus and method for injecting eggs
US4681063A (en) 1986-07-02 1987-07-21 Embrex Inc. High speed automated injection system for avian embryos
JPH07206705A (ja) 1993-11-03 1995-08-08 American Cyanamid Co 生インオボ（ｉｎ ｏｖｏ）ワクチン
GB2298432B (en) 1995-03-03 1999-04-14 Orion Yhtymae Oy In ovo administration of a competitive exclusion culture
ES2224273T3 (es) 1996-09-30 2005-03-01 University Of Arkansas Metodo para producir inmunidad activa por medio de un conjugado de vacuna.
BR9809149A (pt) 1997-05-20 2000-08-01 Galenica Pharmaceuticals Inc Análogos de triterpeno saponina dotados de adjuvante e atividade imonoestimulatória
US6048535A (en) 1997-06-12 2000-04-11 Regents Of The University Of Minnesota Multivalent in ovo avian vaccine
US6019985A (en) 1998-02-27 2000-02-01 Munova Corporation Immunostimulation methods for providing disease protection in poultry
US6410222B1 (en) * 1998-12-14 2002-06-25 Juridical Foundation The Chemosero-Therapeutic Research Institute In ovo vaccination of marek's disease type I virus
US20020187162A1 (en) 2001-04-21 2002-12-12 Geary Steven J. Use of a live attenuated Mycoplasma gallisepticum strain as a vaccine and vector for the protection of chickens and turkeys from respiratory disease
DE60114420T2 (de) 2001-10-04 2006-07-13 Centrum Voor Onderzoek In Diergeneeskunde En Agrochemie Abgeschwächter Mutantenstamm eines Virus der Newcastle-Krankheit für eine in Ovo Impfung und dessen Benutzung

Also Published As

Publication number Publication date
AU2004294810B2 (en) 2010-12-16
ES2422885T3 (es) 2013-09-16
WO2005053737A1 (en) 2005-06-16
US20070116722A1 (en) 2007-05-24
EP1691831A1 (en) 2006-08-23
EP1691831B1 (en) 2013-05-15
CA2547775A1 (en) 2005-06-16
US8092808B2 (en) 2012-01-10
JP4602347B2 (ja) 2010-12-22
AU2004294810C1 (en) 2013-02-14
US8431138B2 (en) 2013-04-30
AU2004294810A1 (en) 2005-06-16
JP2007513138A (ja) 2007-05-24
US20120107351A1 (en) 2012-05-03

Similar Documents

Publication Publication Date Title
JP5014413B2 (ja) 家禽のワクチン接種のための方法及び組成物
JP5229637B2 (ja) サルモネラワクチン
ES2401810T3 (es) Organismos clostridium atenuados y vacuna recombinante
US8431138B2 (en) In ovo vaccination of Campylobacter in avian species
JP2004536106A (ja) マイコプラズマ・ボビスワクチンおよび動物の肺炎を減少させる方法
JP5745731B2 (ja) サルモネラワクチン
US10603371B2 (en) Attenuated Pasteurella multocida vaccines and methods of making and use thereof
US6632439B2 (en) Fusobacterium necrophorum vaccine and method for making such vaccine
BR112015010364B1 (pt) Vacinas atenuadas de mannheimia haemolytica e métodos de produção e uso
KR20220075555A (ko) 락토바실러스 플란타룸의 플랜타리신을 포함하는 배양액과 반응시킨 살모넬라 갈리나룸 불활화 사균체를 포함하는 가금 티푸스의 예방 또는 치료용 백신 조성물
KR100602460B1 (ko) 백신용 약독화 생박테리아
US9764017B2 (en) Potomac horse fever isolates
JP4705573B2 (ja) 弱毒細菌生ワクチン
KR101950931B1 (ko) ptsI 및 crr 유전자 결손된 약독화 살모넬라 타이피뮤리움 균주 및 상기 균주를 이용한 생균 백신 조성물
CHICKEN Dr. Suraksha Subedi Deka

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20181122